These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


222 related items for PubMed ID: 8738668

  • 1. Influence of cyclosporine A and FK506 on 24 h blood pressure monitoring in kidney transplant recipients.
    Hohage H, Brückner D, Arlt M, Buchholz B, Zidek W, Spieker C.
    Clin Nephrol; 1996 May; 45(5):342-4. PubMed ID: 8738668
    [Abstract] [Full Text] [Related]

  • 2. Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy.
    Taler SJ, Textor SC, Canzanello VJ, Wilson DJ, Wiesner RH, Krom RA.
    Am J Hypertens; 1995 Jun; 8(6):598-605. PubMed ID: 7544983
    [Abstract] [Full Text] [Related]

  • 3. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
    Peng LK, Xie XB, Peng FH, Wang Y, Jiang Y, Lan GB, Fang CH, Nie MH.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):59-62. PubMed ID: 17344588
    [Abstract] [Full Text] [Related]

  • 4. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.
    Platz KP, Mueller AR, Jonas S, Blumhardt G, Bechstein WO, Lobeck H, Neuhaus HL.
    Clin Transplant; 1995 Jun; 9(3 Pt 1):146-54. PubMed ID: 7549052
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 6. Blood pressure profile and treatment quality in liver allograft recipients-benefit of tacrolimus versus cyclosporine.
    Dikow R, Degenhard M, Kraus T, Sauer P, Schemmer P, Uhl W, Büchler M, Zeier M.
    Transplant Proc; 2004 Jun; 36(5):1512-5. PubMed ID: 15251373
    [Abstract] [Full Text] [Related]

  • 7. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M, Pellegrini C, Martinelli L, Goggi C, Gavazzi A, Campana C, Arbustini E, Grossi P, Regazzi M, Ippoliti G, Vigano M.
    J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
    [Abstract] [Full Text] [Related]

  • 8. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year.
    Rowshani AT, Scholten EM, Bemelman F, Eikmans M, Idu M, Roos-van Groningen MC, Surachno JS, Mallat MJ, Paul LC, de Fijter JW, Bajema IM, ten Berge I, Florquin S.
    J Am Soc Nephrol; 2006 Jan; 17(1):305-12. PubMed ID: 16306168
    [Abstract] [Full Text] [Related]

  • 9. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus.
    Zawiasa A, Szklarek-Kubicka M, Fijałkowska-Morawska J, Nowak D, Rysz J, Mamełka B, Nowicki M.
    Transplant Proc; 2009 Jan; 41(1):188-91. PubMed ID: 19249511
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B, Kobelt V, Erfmann M, Hausberg M, Gerhardt U, Rahn KH, Hohage H.
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [Abstract] [Full Text] [Related]

  • 11. A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy.
    Kooman JP, Christiaans MH, Boots JM, van Der Sande FM, Leunissen KM, van Hooff JP.
    Am J Kidney Dis; 2001 Jun; 37(6):1170-6. PubMed ID: 11382685
    [Abstract] [Full Text] [Related]

  • 12. Arterial elasticity measurement in renal transplant patients under anticalcineurin immunosuppression.
    Martínez-Castelao A, Sarrias X, Bestard O, Gil-Vernet S, Serón D, Cruzado JM, Moreso F, Díez-Noguera A, Grinyó JM.
    Transplant Proc; 2005 Nov; 37(9):3788-90. PubMed ID: 16386539
    [Abstract] [Full Text] [Related]

  • 13. [Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease].
    Yu LX, Shan HT, Fu SJ, Du CF, Ma JJ, Xu J, Deng WF, Wang YB.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1146-8. PubMed ID: 14625173
    [Abstract] [Full Text] [Related]

  • 14. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients.
    Kanbay M, Akcay A, Huddam B, Usluogullari CA, Arat Z, Ozdemir FN, Haberal M.
    Transplant Proc; 2005 Sep; 37(7):3119-20. PubMed ID: 16213325
    [Abstract] [Full Text] [Related]

  • 15. [Effects of tacrolimus vs cyclosporin-A on bone metabolism after kidney transplantation: a cross-sectional study in 28 patients].
    Albano L, Casez JP, Bekri S, Gigante M, Champenois I, Cassuto-Viguier E, Jaeger P.
    Nephrol Ther; 2005 May; 1(2):115-20. PubMed ID: 16895674
    [Abstract] [Full Text] [Related]

  • 16. Conversion of ciclosporin A to tacrolimus in kidney transplant recipients with chronic allograft nephropathy.
    Tang SC, Chan KW, Tang CS, Lam MF, Leung CY, Tse KC, Li CS, Ho YW, Tong MK, Lai KN, Chan TM, Hong Kong Nephrology Study Group.
    Nephrol Dial Transplant; 2006 Nov; 21(11):3243-51. PubMed ID: 16877482
    [Abstract] [Full Text] [Related]

  • 17. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ, Rossi AF, Courtney M, Gelb BD.
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [Abstract] [Full Text] [Related]

  • 18. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus.
    Chamienia A, Biedunkiewicz B, Król E, Debska-Slizień A, Rutkowski B.
    Transplant Proc; 2006 Dec; 38(1):81-5. PubMed ID: 16504670
    [Abstract] [Full Text] [Related]

  • 19. Pulse wave analysis to assess vascular compliance changes in stable renal transplant recipients.
    Cohen DL, Warburton KM, Warren G, Bloom RD, Townsend RR.
    Am J Hypertens; 2004 Mar; 17(3):209-12. PubMed ID: 15001192
    [Abstract] [Full Text] [Related]

  • 20. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.